About SwitchGear Genomics
SwitchGear Genomics is a Healthcare company based in Menlo Park (United States) founded in 2006, and was acquired by Active Motif in March 2013. It operates as a functional genomics tools and assays are developed for genome research. Its focus areas include Life Sciences, Genomics, Genomics Research and Suite. Its competitors include Rejuvenate Bio, Novogene Corporation, Clinical Microbiomics, BGI and Genewiz and 5 more; 7 of its 10 listed competitors have raised funding.
Company details
SwitchGear Genomics was founded in 2006 in Menlo Park, United States, within the biotechnology sector focused on functional genomics. Functional elements in the human genome are identified, and genomic content is transformed into high-throughput cell-based assays. Products such as reporter constructs, promoter controls, synthetic response elements, miRNA mimics, and enhancer vectors are provided for applications including miRNA target validation, gene regulation studies, transcription factor analysis, and screening processes.
- Headquarters Menlo Park, United States
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website switchgeargenomics.com
- Social X Facebook
- Acquired by Active Motif (Mar 2013)
- Investors
- Acquired byActive Motif
(Mar 2013)
Investors in SwitchGear Genomics
SwitchGear Genomics has secured backing from 1 investor. Prominent investors backing the company include Active Motif.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Epigenetics and gene regulation research tools are developed and distributed. | 1999 | activemotif.com | Carlsbad, United States |
Investor details for SwitchGear Genomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of SwitchGear Genomics
2 dated milestones of SwitchGear Genomics across 7 years, from founding to its latest funding, stage changes and deals.
- Founded SwitchGear Genomics is founded.
- Exit Acquired by Active Motif.
Competitors of SwitchGear Genomics
SwitchGear Genomics has 10 listed competitors in our database, 7 of them funded. They include Rejuvenate Bio, Novogene Corporation, Clinical Microbiomics, BGI and Genewiz, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| rejuvenatebio.com | 2017 | San Diego, United States | $14.58M | 39 | Gene-editing platform and anti-aging therapy for dogs are developed. | |
| novogene.com | 2011 | Beijing, China | $75M | 141 | Genomic services and solutions with NGS expertise are provided. | |
| clinical-microbiomics.com | 2016 | Horsholm, Denmark | $9.71M | 35 | Meta-genomics platforms and services for microbiome studies are provided. | |
| bgi.com | 1999 | Shenzhen, China | – | 25 | BGI is engaged in genomics and precision medicine solutions. | |
| genewiz.com | 1999 | South Plainfield, United States | – | 452 | Genomic services are provided for the life sciences industry. | |
| basecare.cn | 2010 | Suzhou, China | $36.52M | – | NGS-based diagnostic solutions for neonatal screening are developed. | |
| enarabio.com | 2016 | Oxford, United Kingdom | $84.05M | 38 | T-cell interfaces for cancer therapeutics are developed. | |
| 20n.com | 2013 | San Francisco, United States | $2.22M | – | Computational tools are developed to engineer microbes for synthetic biology. | |
| solexa.com | 1992 | Hayward, United States | $14.4M | – | Develops Genome sequencing technology | |
| sourcebioscience.com | 1903 | Nottingham, United Kingdom | – | 273 | Multiple genomic services are provided for analysis and diagnostics. |
Detailed competitors of SwitchGear Genomics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of SwitchGear Genomics
Websites that share an audience with SwitchGear Genomics (switchgeargenomics.com).
Websites whose visitors overlap most with SwitchGear Genomics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
medkoo.com | medkoo.com | 100% | – | #640,352 | – |
| ambion.com | 97% | – | – | View details | |
| asuragen.com | 97% | 8.4K | #2,708,489 | View details | |
insightgenomics.com | insightgenomics.com | 89% | – | – | – |
| bionanogenomics.com | 88% | – | #4,512,022 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for SwitchGear Genomics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as SwitchGear Genomics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SwitchGear Genomics
SwitchGear Genomics was founded in 2006.
SwitchGear Genomics is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
SwitchGear Genomics was founded in 2006 in Menlo Park, United States, within the biotechnology sector focused on functional genomics. Functional elements in the human genome are identified, and genomic content is transformed into high-throughput cell-based assays. Products such as reporter constructs, promoter controls, synthetic response elements, miRNA mimics, and enhancer vectors are provided for applications including miRNA target validation, gene regulation studies, transcription factor analysis, and screening processes.
SwitchGear Genomics's top competitors include Novogene Corporation, BGI and Source BioScience.
SwitchGear Genomics has 1 investor. Key investors include Active Motif.
Yes. SwitchGear Genomics was acquired by Active Motif in March 2013.